about
sameAs
Glycosylation of uroplakins. Implications for bladder physiopathologyWhy is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxiaPeptide-based Antifungal Therapies against Emerging Infections.[Uroplakins as markers of diseases of the urinary system].Vaccines targeting the neovasculature of tumorsHypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth.Hypoxia control to normalize pathologic angiogenesis: potential role for endothelial precursor cells and miRNAs regulation.News on microenvironmental physioxia to revisit skin cell targeting approaches.MicroRNAs and tumor vasculature normalization: impact on anti-tumor immune response.A synthetic androstene derivative and a natural androstene metabolite inhibit relapsing-remitting EAE.Skin Immunity.Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice.Estrogen inhibits systemic T cell expression of TNF-alpha and recruitment of TNF-alpha(+) T cells and macrophages into the CNS of mice developing experimental encephalomyelitis.Estrogen inhibition of EAE involves effects on dendritic cell function.CNS gene expression pattern associated with spontaneous experimental autoimmune encephalomyelitis.Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival[Lewis antigens in human colon carcinoma]Reduced chemokine and chemokine receptor expression in spinal cords of TCR BV8S2 transgenic mice protected against experimental autoimmune encephalomyelitis with BV8S2 proteinMetastatic potential and saccharide antigens expression of human colon cancer cells xenotransplanted into athymic nude mice[Animal lectins--structure and function]Effects of cytokine deficiency on chemokine expression in CNS of mice with EAEInhibitory effects of incomplete Freund's adjuvant on experimental autoimmune encephalomyelitisEndogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice
P50
Q26823952-1A5B8486-DE03-49B5-B5C2-7D9C40026DA1Q33798508-27EA00F5-FA1D-47D2-9033-FC0086AC04A5Q33862289-CB6A1DF7-6748-470E-BBC0-83E98C73B846Q34667655-21BCA18C-0108-4FE1-8A15-7BF428C64B3BQ34704905-90AC7D05-9EFD-4357-9B8B-74830D891905Q37483716-7C896830-B20D-449E-8647-2E533192A9BCQ37996791-E6E53994-8B0D-45BC-9613-650622C0CBA3Q38033656-49941B8F-E071-45A0-B647-7995198A1793Q38098095-7C91102E-1036-4E71-815E-F4F132465BF6Q39317356-BE429DFF-6EDE-4CA9-A179-392FEF215804Q39379300-0E502BCF-5DA4-44A2-8A31-DA18CF681E88Q43648218-958637F9-D31D-442B-AEEA-77A53A80D4CDQ43915322-17570922-A037-4FFC-805B-151F75054B22Q44149897-B9317444-D0EA-4FF3-9171-4829783EFBD9Q47561452-A9B4A90A-5322-43ED-87BD-33424C38D869Q56898156-CAA1A729-B04A-4237-AB4B-DB9F4688CCD1Q73161228-1704AE2B-3350-4C96-B806-86C004CD4ED1Q73567386-64521652-DF8F-4846-8B6A-1B8C5F3F6388Q77576702-CFB57482-032B-4392-B081-0A16FF7FC4EBQ77699373-A52AB2CE-EF61-4742-BA13-FFAE8FD556EBQ77759487-BA468E23-C76E-4C01-A27A-50F81E717E31Q77805679-B6708478-35AC-4E18-AC90-63999BEF5128Q78646848-038060DD-B272-4AE7-893E-2AC9C2A16054
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Agata Matejuk
@ast
Agata Matejuk
@en
Agata Matejuk
@es
Agata Matejuk
@nl
type
label
Agata Matejuk
@ast
Agata Matejuk
@en
Agata Matejuk
@es
Agata Matejuk
@nl
prefLabel
Agata Matejuk
@ast
Agata Matejuk
@en
Agata Matejuk
@es
Agata Matejuk
@nl
P108
P214
P106
P108
P214
P31
P496
0000-0003-2671-7707
P7859
viaf-315215073